See more : Fjordland Exploration Inc. (FEXXF) Income Statement Analysis – Financial Results
Complete financial analysis of Eiken Chemical Co., Ltd. (4549.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Eiken Chemical Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) Income Statement Analysis – Financial Results
- AlphaTime Acquisition Corp (ATMC) Income Statement Analysis – Financial Results
- Shandong Linglong Tyre Co.,Ltd. (601966.SS) Income Statement Analysis – Financial Results
- Wealthy Way Group Limited (3848.HK) Income Statement Analysis – Financial Results
- PT Envy Technologies Indonesia Tbk (ENVY.JK) Income Statement Analysis – Financial Results
Eiken Chemical Co., Ltd. (4549.T)
About Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.05B | 43.27B | 43.00B | 38.66B | 36.59B | 35.76B | 34.99B | 33.27B | 32.16B | 31.02B | 30.03B | 28.65B | 27.70B | 27.56B | 26.84B | 26.11B | 25.23B | 24.65B | 23.55B | 22.87B |
| Cost of Revenue | 23.33B | 22.77B | 22.43B | 20.14B | 20.36B | 20.07B | 20.29B | 19.11B | 18.76B | 18.15B | 17.65B | 17.06B | 16.11B | 16.08B | 15.98B | 15.01B | 14.31B | 13.44B | 12.50B | 11.84B |
| Gross Profit | 16.72B | 20.51B | 20.57B | 18.53B | 16.23B | 15.69B | 14.70B | 14.16B | 13.40B | 12.87B | 12.38B | 11.58B | 11.59B | 11.48B | 10.87B | 11.10B | 10.92B | 11.21B | 11.05B | 11.02B |
| Gross Profit Ratio | 41.76% | 47.39% | 47.84% | 47.92% | 44.37% | 43.88% | 42.01% | 42.57% | 41.67% | 41.49% | 41.22% | 40.43% | 41.84% | 41.66% | 40.48% | 42.50% | 43.27% | 45.46% | 46.90% | 48.21% |
| Research & Development | 3.94B | 4.07B | 3.41B | 3.09B | 3.33B | 2.90B | 3.24B | 2.34B | 2.27B | 2.46B | 1.95B | 1.84B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.41B | 8.98B | 8.78B | 8.83B | 8.28B | 8.18B | 7.98B | 7.85B | 7.59B | 7.59B | 7.42B | 7.19B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 2.00M | 106.00M | 95.00M | 182.00M | 90.00M | 74.00M | 84.00M | 102.00M | 52.00M | 74.00M | 73.00M | 233.00M | 201.00M | 93.00M | 112.00M | 248.00M | -168.00M | -91.00M | 30.68M | 109.14M |
| Operating Expenses | 13.35B | 13.05B | 12.18B | 11.91B | 11.61B | 11.08B | 11.22B | 10.19B | 9.87B | 10.04B | 9.37B | 9.03B | 9.23B | 8.77B | 8.96B | 9.27B | 8.87B | 9.39B | 9.05B | 9.32B |
| Cost & Expenses | 36.68B | 35.81B | 34.62B | 32.05B | 31.96B | 31.15B | 31.51B | 29.30B | 28.63B | 28.19B | 27.02B | 26.10B | 25.34B | 24.85B | 24.94B | 24.28B | 23.18B | 22.83B | 21.55B | 21.16B |
| Interest Income | 8.00M | 15.00M | 18.00M | 17.00M | 8.00M | 4.00M | 4.00M | 6.00M | 7.00M | 11.00M | 4.00M | 6.00M | 2.00M | 0.00 | 3.00M | 9.00M | 5.00M | 0.00 | 278.00K | 2.49M |
| Interest Expense | 17.00M | 16.00M | 7.00M | 2.00M | 4.00M | 7.00M | 8.00M | 9.00M | 9.00M | 8.00M | 13.00M | 20.00M | 24.00M | 13.00M | 4.00M | 2.00M | 2.00M | 1.00M | 991.00K | 938.00K |
| Depreciation & Amortization | 2.33B | 2.13B | 2.06B | 1.71B | 1.63B | 1.59B | 1.66B | 1.56B | 1.43B | 1.25B | 1.11B | 1.04B | 1.02B | 923.00M | 922.00M | 906.00M | 803.00M | 721.00M | 762.41M | 809.61M |
| EBITDA | 5.85B | 9.58B | 10.45B | 8.32B | 6.25B | 6.20B | 5.13B | 5.53B | 4.96B | 4.07B | 4.11B | 4.80B | 3.43B | 3.58B | 2.86B | 2.81B | 3.70B | 2.54B | 2.81B | 1.61B |
| EBITDA Ratio | 14.59% | 22.47% | 24.59% | 22.05% | 17.37% | 17.59% | 14.93% | 17.00% | 15.60% | 13.81% | 14.10% | 13.56% | 12.92% | 13.45% | 10.95% | 11.41% | 10.65% | 9.91% | 11.86% | 11.48% |
| Operating Income | 3.38B | 7.46B | 8.39B | 6.61B | 4.62B | 4.61B | 3.48B | 3.98B | 3.54B | 2.83B | 3.01B | 2.55B | 2.36B | 2.71B | 1.90B | 1.83B | 2.05B | 1.82B | 2.00B | 1.71B |
| Operating Income Ratio | 8.43% | 17.23% | 19.50% | 17.10% | 12.63% | 12.89% | 9.94% | 11.95% | 10.99% | 9.11% | 10.02% | 8.90% | 8.53% | 9.83% | 7.09% | 7.00% | 8.13% | 7.38% | 8.49% | 7.46% |
| Total Other Income/Expenses | 126.00M | 135.00M | 95.00M | 258.00M | 102.00M | 38.00M | -4.00M | -131.00M | -146.00M | 178.00M | 51.00M | 1.19B | 26.00M | -67.00M | 29.00M | 74.00M | 844.00M | -3.00M | 49.05M | -902.65M |
| Income Before Tax | 3.50B | 7.59B | 8.48B | 6.87B | 4.72B | 4.65B | 3.47B | 3.85B | 3.39B | 3.00B | 3.06B | 3.74B | 2.39B | 2.64B | 1.93B | 1.90B | 2.90B | 1.82B | 2.05B | 802.52M |
| Income Before Tax Ratio | 8.75% | 17.55% | 19.72% | 17.77% | 12.91% | 13.00% | 9.93% | 11.56% | 10.54% | 9.69% | 10.19% | 13.06% | 8.62% | 9.59% | 7.20% | 7.29% | 11.48% | 7.37% | 8.70% | 3.51% |
| Income Tax Expense | 869.00M | 1.86B | 2.26B | 1.83B | 1.19B | 1.20B | 865.00M | 926.00M | 960.00M | 904.00M | 1.07B | 1.29B | 929.00M | 970.00M | 718.00M | 766.00M | 1.23B | 734.00M | 822.72M | 384.15M |
| Net Income | 2.63B | 5.74B | 6.22B | 5.04B | 3.54B | 3.45B | 2.61B | 2.92B | 2.43B | 2.10B | 1.98B | 2.45B | 1.46B | 1.67B | 1.21B | 1.14B | 1.67B | 1.08B | 1.23B | 418.38M |
| Net Income Ratio | 6.58% | 13.26% | 14.46% | 13.05% | 9.67% | 9.64% | 7.45% | 8.77% | 7.55% | 6.77% | 6.61% | 8.56% | 5.27% | 6.07% | 4.52% | 4.35% | 6.62% | 4.38% | 5.20% | 1.83% |
| EPS | 71.69 | 155.17 | 168.26 | 136.63 | 95.93 | 93.61 | 71.18 | 79.69 | 66.43 | 57.57 | 54.57 | 67.49 | 40.19 | 46.03 | 33.44 | 28.72 | 42.15 | 23.29 | 27.52 | 8.40 |
| EPS Diluted | 71.09 | 153.86 | 166.98 | 135.59 | 95.19 | 92.84 | 70.34 | 78.80 | 65.72 | 56.93 | 53.92 | 66.78 | 39.83 | 45.70 | 33.25 | 28.62 | 42.09 | 23.29 | 27.52 | 8.40 |
| Weighted Avg Shares Out | 36.74M | 36.97M | 36.96M | 36.92M | 36.88M | 36.82M | 36.64M | 36.62M | 36.57M | 36.48M | 36.38M | 36.35M | 36.33M | 36.33M | 36.31M | 39.59M | 39.62M | 46.41M | 44.53M | 46.25M |
| Weighted Avg Shares Out (Dil) | 37.05M | 37.28M | 37.24M | 37.20M | 37.17M | 37.13M | 37.08M | 37.03M | 36.96M | 36.89M | 36.80M | 36.73M | 36.66M | 36.59M | 36.51M | 39.73M | 39.68M | 46.41M | 44.53M | 46.25M |
Source: https://incomestatements.info
Category: Stock Reports